Open AccessRisk of Selected Cardiovascular Toxicities in Patients With Cancer Treated With MEK Inhibitors: A Comparative Systematic Review and Meta-Analysis
Author(s) -
Omar AbdelRahman,
Hesham Elhalawani,
Hoda Ahmed
Publication year - 2015
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.2015.000802
Subject(s) - medicine , selumetinib , meta analysis , trametinib , randomized controlled trial , mek inhibitor , lower risk , medline , oncology , cancer , mapk/erk pathway , kinase , confidence interval , colorectal cancer , political science , law , kras , biology , microbiology and biotechnology
We conducted a literature-based meta-analysis of the risk of cardiovascular toxicities associated with MEK inhibitors.